(Il Sole 24 Ore Radiocor) - Milano, 20 mag - Thermo Fisher Scientific said it expected to deliver 7% annual organic revenue growth and low-teens adjusted earnings-per-share growth over the long term.

The company, at an investor day, said its market had improving demand trends and strong long-term growth fundamentals.

It said AI would accelerate scientific breakthroughs and improve productivity and returns on drug discovery.

"We are uniquely positioned to capture AI-driven growth through our presence across the full drug development value.

chain," it said.

(RADIOCOR) 20-05-26 15:24:30 (0506) 5 NNNN